Competition Law and Public Sector Innovation Markets

1. Introduction

Public sector innovation markets arise where governments, public-sector undertakings, statutory authorities, universities, public research institutions, or government-created platforms participate in markets involving research, technology development, innovative procurement, intellectual property, data, infrastructure, digital platforms, AI, healthcare, energy, defence-related civilian technologies, and other emerging products or services.

Competition law becomes important because the public sector can simultaneously act as:

1. Regulator;
2. Purchaser or procurer;
3. Market participant;
4. Owner of infrastructure or data;
5. Provider of innovation funding; and
6. Potential competitor to private enterprises.

Innovation markets are particularly sensitive because competition may occur not merely over today's prices and products, but over future technologies, R&D pipelines, standards, patents, data, algorithms and technological trajectories. EU case-law, for example, recognises that competition can be affected when conduct reduces competitors' incentives or ability to innovate.

2. Meaning of Public Sector Innovation Markets

A public-sector innovation market can be understood as a market in which a public body or publicly controlled undertaking:

• develops new technology;
• funds R&D;
• purchases innovative products;
• owns essential technological infrastructure;
• commercialises publicly funded research;
• licenses public-sector intellectual property;
• controls important public datasets;
• operates a digital or technological platform;
• establishes technical standards;
• or competes with private firms in an innovation-intensive market.

Examples include:

• government-funded AI platforms;
• public cloud infrastructure;
• government health-tech systems;
• smart-grid technology;
• public EV charging infrastructure;
• defence-adjacent civilian technologies;
• public biotechnology research;
• government-owned telecommunications infrastructure;
• public universities licensing patents;
• digital identity infrastructure;
• public procurement of autonomous vehicles or drones.

3. Why Competition Law Matters

Innovation competition differs from conventional price competition.

A firm may compete through:

Price + quality + technology + R&D + data + patents + interoperability + future product development.

Consequently, a public entity may distort competition even without charging excessive prices.

For example, suppose a government-owned research platform develops a new AI technology and subsequently:

• refuses interoperability;
• gives exclusive access to one company;
• licenses the technology only to its own subsidiary;
• provides privileged research data to one undertaking;
• uses public procurement to exclude competing technologies;
• or acquires a promising private innovator.

The immediate price effect may be negligible, but future innovation competition may be reduced.

4. Indian Competition-Law Framework

A. Competition Act, 2002

The Competition Act applies to enterprises irrespective of whether they are privately or publicly owned, subject to the statutory exclusion for activities relating to sovereign functions.

Section 2(h) defines an "enterprise" by reference to economic activities rather than merely private ownership.

The important principle is therefore:

Government ownership does not automatically place an activity outside competition law.

This is particularly important for public innovation markets because government entities increasingly undertake activities that resemble ordinary economic activities.

The Competition Appellate Tribunal in Rajat Verma v. Haryana Public Works (B&R) Department emphasised that the Competition Act does not create a general distinction between public and private entities when they interface with markets.

5. Relevant Competition Concerns

A. Public Research Monopolies

A government research institution may control:

• patents;
• research datasets;
• laboratories;
• scientific infrastructure;
• specialised testing facilities;
• technical standards;
• or proprietary technology.

If access is denied selectively, the institution can potentially create a barrier to downstream competition.

The competition question is:

Does control over public research infrastructure permit foreclosure of competing innovators?

B. Preferential Access to Publicly Funded Innovation

A major concern arises when one private company receives preferential access to:

• government-funded patents;
• public datasets;
• research facilities;
• government-developed algorithms;
• public testing infrastructure;
• government grants;
• or publicly funded technology.

This can create an artificial competitive advantage.

The analysis should examine:

1. whether the resource is commercially important;
2. whether alternative sources exist;
3. whether access is objectively necessary;
4. whether access conditions are discriminatory;
5. whether the beneficiary is competing with other users;
6. whether the arrangement forecloses rivals.

6. Public Procurement and Innovation Competition

Public procurement can either promote or suppress innovation.

A procurement authority may unintentionally favour an incumbent by specifying:

• a particular proprietary technology;
• a particular technical architecture;
• restrictive certification requirements;
• excessive prior-experience requirements;
• proprietary interoperability standards;
• unnecessarily large minimum contract sizes.

This can prevent startups and new technologies from entering the market.

Innovation-friendly procurement

A competition-sensitive procurement framework should preferably specify:

Outcome → Functional requirement → Performance standard

rather than:

Existing technology → Proprietary specification → Mandatory incumbent technology.

Recent EU materials similarly emphasise functional/performance requirements, participation of startups and multiple sourcing as tools for reducing supplier lock-in and fostering innovation competition.

7. Public Funding and State-Aid Concerns

Public innovation funding can create a second competition-law problem.

Government may provide:

• grants;
• subsidised loans;
• tax benefits;
• guarantees;
• infrastructure;
• research facilities;
• preferential licensing;
• land;
• or government procurement commitments.

Such support can give selected firms an advantage over competitors.

Under EU State-aid principles, selective advantages provided through State resources can constitute State aid where the applicable conditions are satisfied.

This is particularly important in innovation markets because subsidies can determine which technology becomes commercially viable.

8. Public Sector Innovation and Abuse of Dominance

Suppose a public enterprise controls a critical innovation platform.

Potential abuses include:

1. Refusal to deal

Refusing access to indispensable technology or infrastructure.

2. Discriminatory access

Providing favourable access to affiliated enterprises.

3. Self-preferencing

Giving the public body's own commercial subsidiary preferential access.

4. Tying

Requiring businesses to use another public-sector product or service.

5. Exclusive dealing

Requiring innovators to use a particular public platform exclusively.

6. Predatory or subsidised pricing

Using public resources to eliminate private competitors.

7. Excessive licensing restrictions

Imposing unreasonable conditions on publicly controlled IP.

8. Interoperability restrictions

Preventing rival technologies from connecting with the public platform.

9. Innovation Markets and Merger Control

Innovation competition also matters in mergers.

A conventional market-share analysis can miss an important problem where:

Company A has a small current market share but owns a promising technology that could become a major competitive constraint.

A merger between a dominant incumbent and an innovative startup can therefore eliminate potential competition.

The assessment may examine:

• R&D pipelines;
• patents;
• research teams;
• technological capabilities;
• future products;
• innovation incentives;
• nascent competitors;
• access to data;
• interoperability;
• and likelihood of future market entry.

EU competition scholarship and case-law increasingly distinguish competition over existing products from competition through future innovation and R&D.

10. Six Important Case Laws

1. Rajat Verma v. Haryana Public Works (B&R) Department

Competition Appellate Tribunal, 2016

Principle

This is particularly important for public-sector competition analysis.

The dispute concerned government procurement of construction services. The Tribunal examined whether a government department could constitute an "enterprise" under the Competition Act.

The Tribunal stressed that the Competition Act focuses on the economic activity and market interface, rather than simply the public or private character of the entity.

Relevance to innovation markets

The same principle can apply to public technology procurement.

If a government department:

• purchases technology;
• provides technological services;
• controls an economic infrastructure;
• or participates in an innovation market,

its public ownership does not automatically immunise the activity from competition scrutiny.

Key lesson:
Public-sector status alone is not a defence where the activity is economic rather than sovereign.

11. India Trade Promotion Organisation v. CCI

COMPAT, 2016

ITPO was a government-owned, non-profit entity managing Pragati Maidan.

The case concerned restrictions on competing exhibition organisers and allegations that ITPO's policies disadvantaged competing organisers.

The Tribunal examined:

• whether ITPO was an enterprise;
• relevant market;
• dominance;
• discriminatory conditions;
• and restrictions on market access. 

Relevance

The case illustrates how control over a strategically important public facility can produce competition concerns.

In an innovation market, the equivalent might be:

• a public laboratory;
• public testing facility;
• government technology platform;
• public data infrastructure;
• or public research marketplace.

Key lesson:
Control of a publicly owned facility can become a competition-law issue when access conditions affect competing market participants.

12. Sudarshan Kumar Kapur v. Delhi Development Authority

CCI, Case No. 78 of 2016

The CCI considered DDA's activities involving development and sale of residential plots and treated those activities as economic rather than sovereign.

The case is significant because a government authority's statutory origin did not prevent its economic activities from being analysed under competition law.

Relevance to innovation markets

A public authority controlling:

• technology parks;
• innovation zones;
• research facilities;
• land for technology infrastructure;
• or digital infrastructure

may similarly be subject to competition scrutiny when it engages in economic activities.

Key lesson:
The functional nature of the activity matters more than governmental ownership.

13. Nungesser v. Commission

Case 258/78, Court of Justice of the European Union

This case concerned technology licensing and exclusive rights.

The Court recognised the relationship between certain licensing arrangements and the promotion of technological development and innovation.

Relevance

Public research institutions frequently commercialise inventions through:

• exclusive licences;
• technology-transfer agreements;
• research collaborations.

Competition law must therefore distinguish between:

legitimate incentives for innovation

and

unnecessary restrictions that eliminate competitive technology development.

The case is frequently discussed in relation to the proposition that appropriately structured exclusivity can sometimes facilitate technological innovation.

14. Microsoft v. Commission

Case T-201/04

Microsoft's refusal to provide interoperability information was examined under Article 102 TFEU.

The case is especially relevant because the Court accepted that refusal to provide interoperability information could affect competitors' ability to develop competing products.

The innovation dimension was important: restrictions on interoperability could reduce competitors' ability and incentives to innovate.

Public-sector application

Imagine a government-owned digital platform controlling:

• identity APIs;
• public payment infrastructure;
• health-data interfaces;
• public cloud systems;
• or digital-government protocols.

If competitors cannot meaningfully interoperate, innovation may be weakened.

Key lesson:
Interoperability can be a competition parameter in technology markets.

15. Tetra Laval v. Commission

Case T-5/02

The case is important for merger analysis involving innovation and future competitive effects.

The European courts stressed that claims concerning reduced innovation cannot simply be asserted; the authority must establish a sufficiently substantiated causal connection between the transaction and the anticipated competitive harm.

Relevance

This principle is particularly important for public-sector innovation markets.

A proposed acquisition of an innovative startup should not be challenged merely because the target possesses interesting technology.

The competition assessment should investigate:

• technological capability;
• R&D incentives;
• likelihood of independent development;
• competitive constraints;
• alternative innovators;
• and the probable effect of the transaction.

The EU case-law literature identifies Tetra Laval as an important early case concerning harm to innovation.

16. AstraZeneca v. Commission

Case T-321/05

AstraZeneca concerned conduct relating to pharmaceutical intellectual-property rights.

The General Court considered how misuse of the patent system could prolong exclusivity and potentially reduce incentives for innovation and competitive entry.

Relevance

The case illustrates a crucial distinction:

IP protection can reward innovation, but strategic misuse of regulatory/IP mechanisms can potentially protect market power beyond what innovation policy requires.

For public research institutions, this becomes relevant when publicly funded inventions are licensed or protected in ways that unnecessarily foreclose alternative technologies.

The EU case-law literature specifically identifies AstraZeneca as a case where reduced innovation incentives were relevant to the competition analysis.

17. GlaxoSmithKline v. Commission

Joined Cases T-168/01 and C-501/06 P

The pharmaceutical cases are significant because the Court recognised the special importance of competition through innovation in pharmaceutical markets.

The analysis demonstrated that competition may occur through parameters other than price, particularly innovation.

Relevance

This is directly transferable to public innovation markets such as:

• biotechnology;
• pharmaceuticals;
• medical devices;
• clean technology;
• AI;
• energy technology.

A public-sector competition analysis should therefore avoid looking only at current prices and market shares.

Key lesson:
Innovation itself can constitute an important dimension of competition.

18. Summary of the Six-Plus Case Principles

19. Public Research Institutions

Universities and government laboratories present a particularly interesting problem.

They can simultaneously be:

Researcher → Patent owner → Licensor → Grant recipient → Procurement authority → Commercial participant

Competition issues may arise where a university:

• exclusively licenses publicly funded research;
• gives preferential treatment to a spin-off;
• restricts competing licensees;
• bundles patents;
• controls essential research facilities;
• restricts access to datasets;
• or coordinates commercially sensitive research activities among competing companies.

The correct analysis requires balancing two objectives:

Innovation incentive

Researchers need sufficient incentives to:

• invent;
• patent;
• commercialise;
• invest;
• collaborate.

Competitive access

Other firms may need sufficient access to:

• technology;
• research infrastructure;
• data;
• standards;
• scientists;
• patents;
• and interoperability.

20. Public Innovation Platforms

Modern governments increasingly create platforms comparable to private digital ecosystems.

Examples include:

• digital identity platforms;
• government payment systems;
• public health platforms;
• public cloud;
• procurement platforms;
• agricultural data platforms;
• energy-data exchanges;
• public AI infrastructure.

These platforms can generate network effects.

The larger the user base becomes:

More users → more data → better technology → more users → stronger ecosystem → higher entry barriers.

Consequently, a public platform can become a bottleneck even without conventional commercial pricing.

21. Data as an Innovation Asset

Public datasets can be critical innovation inputs.

Examples include:

• healthcare data;
• transport data;
• environmental data;
• cadastral data;
• meteorological data;
• agricultural data;
• public research datasets.

Competition concerns arise if the government:

1. makes data available to one firm but not others;
2. imposes discriminatory access fees;
3. permits its own subsidiary preferential access;
4. bundles data with another service;
5. restricts interoperability;
6. creates unnecessarily exclusive data rights.

The analysis should distinguish legitimate privacy, security and public-interest restrictions from restrictions that unnecessarily suppress competition.

22. Public Procurement as an Innovation Tool

Competition law should not treat public procurement merely as purchasing.

Government procurement can create an innovation market-shaping effect.

For example:

Traditional procurement

Government specifies:

"Supply technology X manufactured according to specification Y."

Innovation-oriented procurement

Government specifies:

"Provide a system capable of achieving performance objectives A, B and C."

The second approach potentially allows:

• startups;
• alternative technologies;
• competing architectures;
• new business models;
• and emerging technologies

to compete.

23. Lock-In and Switching Costs

Public-sector innovation platforms can create significant lock-in.

Examples:

• government cloud;
• public payment systems;
• digital identity;
• electronic health records;
• public transport cards;
• smart-grid infrastructure.

Lock-in becomes a competition concern where users cannot reasonably migrate because:

• data cannot be exported;
• APIs are unavailable;
• technical standards are proprietary;
• switching costs are excessive;
• contracts prohibit interoperability;
• or public infrastructure is controlled by a dominant provider.

24. Public–Private Partnerships

Public-private innovation partnerships create another competition-law problem.

A government may collaborate with a private company to develop technology.

Potential concerns include:

• exclusive technology rights;
• allocation of patents;
• exclusivity periods;
• non-compete provisions;
• data ownership;
• downstream licensing;
• access to research infrastructure;
• and preferential procurement after development.

A carefully drafted agreement should therefore determine:

1. who owns background IP;
2. who owns foreground IP;
3. licensing rights;
4. access rights;
5. interoperability obligations;
6. publication rights;
7. exclusivity duration;
8. competing research rights;
9. data access;
10. termination and technology-transfer arrangements.

25. Innovation-Neutrality Principle

A useful competition-policy principle is:

Public support for innovation should generally compete on technological merit rather than create artificial exclusion of alternative technologies.

This does not mean every government innovation programme must treat every technology identically.

Government may legitimately prioritise:

• national security;
• environmental objectives;
• public health;
• strategic technologies;
• regional development;
• resilience;
• or social objectives.

The competition question is whether the chosen mechanism unnecessarily excludes competing market participants.

26. Competition Assessment Framework

A public-sector innovation measure can be examined through the following sequence:

Step 1 — Identify the public entity

Is it:

• government department?
• PSU?
• statutory authority?
• public university?
• government-controlled corporation?
• research institution?

Step 2 — Identify the activity

Is the activity:

• sovereign?
• regulatory?
• economic?
• procurement?
• research?
• licensing?
• commercialisation?

Step 3 — Define the market

Identify:

• product/technology market;
• geographic market;
• innovation pipeline;
• upstream/downstream markets.

Step 4 — Identify the innovation asset

Examples:

• patent;
• data;
• algorithm;
• infrastructure;
• standard;
• research facility;
• API;
• technology platform.

Step 5 — Examine market power

Consider:

• market share;
• technological superiority;
• switching costs;
• network effects;
• IP protection;
• access barriers;
• dependency of downstream firms.

Step 6 — Examine conduct

Look for:

• exclusion;
• discrimination;
• tying;
• refusal of access;
• exclusive licensing;
• self-preferencing;
• predatory pricing;
• procurement discrimination.

Step 7 — Examine innovation effects

Ask:

Does the conduct reduce the ability or incentive of competitors to innovate?

Step 8 — Examine efficiencies

Consider:

• R&D efficiencies;
• technological integration;
• economies of scale;
• public-interest benefits;
• faster commercialisation.

Step 9 — Consider less restrictive alternatives

Could the same public objective be achieved through:

• open standards;
• non-exclusive licensing;
• competitive procurement;
• interoperability;
• multiple sourcing;
• transparent access criteria?

27. Major Competition Risks

28. Remedies

Competition authorities may consider remedies such as:

Structural remedies

• divestiture;
• separation of commercial and regulatory functions;
• separation of infrastructure from downstream services.

Behavioural remedies

• non-discriminatory access;
• transparent licensing;
• interoperability;
• data portability;
• fair procurement criteria;
• prohibition of exclusive arrangements.

Innovation remedies

• continued R&D investment;
• access to research facilities;
• licensing commitments;
• preservation of competing R&D projects.

Procurement remedies

• technology-neutral specifications;
• functional requirements;
• multiple sourcing;
• transparent qualification criteria.

29. Key Distinction: Public Interest vs Competition

A public-sector innovation measure may pursue legitimate public objectives.

For example:

Public objective: develop strategic AI capability.

That does not automatically mean:

Competition consequence: give one company permanent exclusive access to public AI infrastructure.

The legally important question is whether the means chosen to achieve the public objective unnecessarily restrict competition.

This distinction is particularly important because public innovation policy and competition policy can sometimes point in different directions.

30. Emerging Issues

Public-sector innovation markets are increasingly affected by:

Artificial Intelligence

Government datasets, public compute infrastructure and AI procurement can create significant competitive advantages.

Cloud Computing

Public cloud procurement can create long-term vendor lock-in.

Biotechnology

Public research institutions may control foundational patents and biological datasets.

Energy Technology

Government-owned grids and public charging infrastructure can determine which technologies gain market access.

Quantum Technology

Public R&D funding can determine access to highly concentrated technological capabilities.

Digital Identity

Government identity infrastructure can become an essential interface for private digital services.

Smart Cities

Public platforms can control data, APIs and infrastructure used by multiple competing providers.

31. Overall Legal Position

The central competition-law principle is that public ownership does not itself determine whether competition law applies. What matters is the nature of the activity and its interaction with the market.

For innovation markets, competition law must look beyond:

current price + current market share

and consider:

R&D + future products + technology + data + IP + interoperability + potential competition + innovation incentives.

The Indian cases concerning Haryana PWD, ITPO and DDA demonstrate the importance of analysing governmental bodies according to their economic activities, while EU cases such as Nungesser, Microsoft, Tetra Laval, AstraZeneca and GlaxoSmithKline demonstrate how competition law can incorporate technological development and innovation into the analysis.

Conclusion

Competition law and public-sector innovation markets intersect at the point where government participation in innovation begins to affect competitive conditions.

The principal legal concerns are:

1. public-sector dominance;
2. exclusive access to public research;
3. discriminatory procurement;
4. publicly funded IP foreclosure;
5. data-access discrimination;
6. interoperability restrictions;
7. public subsidies and competitive neutrality;
8. innovation-killing mergers;
9. technology lock-in; and
10. preferential treatment of public or affiliated undertakings.

The appropriate competition-law approach is therefore not to treat public-sector innovation as inherently anti-competitive. Rather, it is to determine whether the design or conduct of the public entity preserves meaningful opportunities for competing firms to innovate, enter, interoperate and develop alternative technologies while allowing legitimate public-interest innovation objectives to be achieved.